Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy
Liwei Jiang, Yi‐Jun Wang, Jing Zhao, et al.
Cell (2020) Vol. 183, Iss. 5, pp. 1219-1233.e18
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
Peijie Wu, Wei Gao, Miao Su, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 150
Big data in basic and translational cancer research
Peng Jiang, Sanju Sinha, Kenneth Aldape, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 11, pp. 625-639
Open Access | Times Cited: 148
Engineering Multienzyme‐Mimicking Covalent Organic Frameworks as Pyroptosis Inducers for Boosting Antitumor Immunity
Liang Zhang, Qi‐Chao Yang, Shuo Wang, et al.
Advanced Materials (2021) Vol. 34, Iss. 13
Closed Access | Times Cited: 144
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
Juan Dubrot, Peter P. Du, Sarah Kate Lane-Reticker, et al.
Nature Immunology (2022) Vol. 23, Iss. 10, pp. 1495-1506
Closed Access | Times Cited: 115
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 25
Parallel single-cell and bulk transcriptome analyses reveal key features of the gastric tumor microenvironment
Boxi Kang, J. Camps, Biao Fan, et al.
Genome biology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 45
Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity
Karoliina Tuomela, Ashley Ambrose, Daniel M. Davis
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 39
A Polymeric Extracellular Matrix Nanoremodeler for Activatable Cancer Photo‐Immunotherapy
Chi Zhang, Mengke Xu, Ziling Zeng, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 12
Open Access | Times Cited: 32
Activatable Immunoprotease Nanorestimulator for Second Near-Infrared Photothermal Immunotherapy of Cancer
Mengke Xu, Chi Zhang, Shasha He, et al.
ACS Nano (2023) Vol. 17, Iss. 9, pp. 8183-8194
Closed Access | Times Cited: 28
In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer
Dzana Dervovic, Ahmad Malik, Edward L. Y. Chen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Epigenetic reprogramming of Runx3 reinforces CD8 + T-cell function and improves the clinical response to immunotherapy
Zongzhi Liu, Xiang Li, Yibo Gao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and Fas inhibition
Melisa J. Montalvo, Irfan Bandey, Ali Rezvan, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 7
SP3-Enabled Rapid and High Coverage Chemoproteomic Identification of Cell-State–Dependent Redox-Sensitive Cysteines
Heta S. Desai, Tianyang Yan, Fengchao Yu, et al.
Molecular & Cellular Proteomics (2022) Vol. 21, Iss. 4, pp. 100218-100218
Open Access | Times Cited: 35
Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma
Lizhi Pang, Songlin Guo, Fatima Khan, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101238-101238
Open Access | Times Cited: 17
SERPINA12 promotes the tumorigenic capacity of HCC stem cells through hyperactivation of AKT/β-catenin signaling
Huajian Yu, Lei Zhou, Jane Ho Chun Loong, et al.
Hepatology (2023) Vol. 78, Iss. 6, pp. 1711-1726
Closed Access | Times Cited: 15
MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer
Masayuki Hagiwara, Atsushi Fushimi, Atrayee Bhattacharya, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Inhibition of SerpinB9 to enhance granzyme B-based tumor therapy by using a modified biomimetic nanoplatform with a cascade strategy
Ran Han, Luting Yu, Chenxuan Zhao, et al.
Biomaterials (2022) Vol. 288, pp. 121723-121723
Closed Access | Times Cited: 24
Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME
Vijay Kumar, Caitlin Bauer, John H. Stewart
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 14
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression
Tzu‐Po Chuang, Wei‐Yun Lai, Jonatan L. Gabre, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 8
Open Access | Times Cited: 13
Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis
Xiangkun Wu, Hong Yan, Mingxing Qiu, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 13
A General Molecular Structural Design for Highly Efficient Photopyroptosis that can be Activated within 10 s Irradiation
Qingsong Liu, Xianxian Yao, Lulu Zhou, et al.
Advanced Materials (2024) Vol. 36, Iss. 29
Closed Access | Times Cited: 3
Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer
Kristian M. Hargadon
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 2
Open Access | Times Cited: 10
SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response
Sofía Ibáñez-Molero, Alex van Vliet, Joanna Poźniak, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Formyl peptide enhances cancer immunotherapy by activating antitumoral neutrophils, and T cells
Sun Haixia, Shuxin Li, Qiao-Li Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116670-116670
Open Access | Times Cited: 2
Immunogenic cell death effects induced by doxorubicin improved chemo-immunotherapy via restoration of granzyme B activity
Tao Huang, Xiaofan Sun, Yingqiu Qi, et al.
Nano Research (2023) Vol. 16, Iss. 12, pp. 13250-13258
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top